Clinical Trials Directory

Trials / Completed

CompletedNCT02976350

Hormone Deficiency in Heart Failure With Preserved Ejection Fraction

Multiple Hormone Deficiency Syndrome in Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Federico II University · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to describe the prevalence of Multiple Hormone Deficiencies in Heart Failure with preserved Ejection Fraction.

Detailed description

Despite the effectiveness of the neurohormonal model to explain the progression of heart failure and the many insights that it provided for the development of new therapies, there is increasing clinical evidence that suggests that our current models fail to completely explain the disease progression. Thus, neurohormonal models may be necessary but not sufficient to explain all aspects of disease progression in the failing heart. There is evidence suggesting that in heart failure there is a metabolic imbalance characterized by the predominance of the catabolic status over the anabolic drive. Consistent data coming from several independent groups have documented the reduced activity of most anabolic axes in HF with reduced ejection fraction. To date, no study has addressed the prevalence the presence and the prevalence of the Multiple Hormone Deficiencies in Heart Failure with preserved Ejection Fraction.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2015-04-01
Completion
2015-09-01
First posted
2016-11-29
Last updated
2016-11-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02976350. Inclusion in this directory is not an endorsement.

Hormone Deficiency in Heart Failure With Preserved Ejection Fraction (NCT02976350) · Clinical Trials Directory